Beijing ZhongShuo Pharmaceutical
Manufacturer
Business Nature
Manufacturer
No. Employees
101 - 200 People
Year Established
2012
Annual Turnover
Approx 0.8 Million US Dollar
Country/Region
Beijing, China
Main Products
API
Legal Status
Third Party
Payment Terms
Bank wire (T/T), Letter of Credit (L/C), Credit Card (CC), Cash
About Beijing ZhongShuo Pharmaceutical
If you are surveying for a identified China API, pharmaceutical intermediate, Entecaivr Monohydrate, paclitaxel, Docetaxel, Cabazitaxe, Adefovir Dipivoxil, Alogliptin, Doxorubicin Hydrochloride, Tenofovir Disoproxil Fumarate, Sitafloxacin, Phenazapam, Roflumilast, Valsartan Manufacturer that has speciallized in Medical & Healthcare, then Beijing ZhongShuo Pharmaceutical is the best option. The branch of Beijing ZhongShuo Pharmaceutical is sited in Beijing Beijing China. Beijing ZhongShuo Pharmaceutical is a finest enterprise positioned in China. Beijing ZhongShuo Pharmaceutical Facts Name: Anne Yu
Address: Beijing Beijing
Country: China
Main Products: API, pharmaceutical intermediate, Entecaivr Monohydrate, paclitaxel, Docetaxel, Cabazitaxe, Adefovir Dipivoxil, Alogliptin, Doxorubicin Hydrochloride, Tenofovir Disoproxil Fumarate, Sitafloxacin, Phenazapam, Roflumilast, Valsartan
Year Established: 2012
Export Focus: Australia, Canada, Germany, South Korea, United Kingdom
Estimated Employees: 101 - 200 People
Registered Capital: US$50 Million - US$100 Million
Ownership Status: Professional Association
Export Percentage: 91% - 100%
Factory Size: 1, 000-3, 000 square meters
Production Lines: 1
Research Team Size: Fewer than 5
Contract Services: Design Service Offered
Main Markets
Products
View All ProductsSend Your Inquiry Direct To This Supplier
Frequently Asked Questions - FAQ's
Trending Suppliers
API, pharmaceutical intermediates, Linagliptin, Azil...
Alogliptin
API, pharmaceutical intermediate, Entecaivr Monohydra...
sales Cytarabine, Alogliptin benzoate